Details for: MULTIPLUS

Product description

Product name: MULTIPLUS

Company name: VITA HEALTH PRODUCTS INC

DIN: 02239852

Status: Cancelled Post Market

Status date: 2004-07-26

Active ingredient(s)	Strength
ASCORBIC ACID	100 MG / TAB
BETA-CAROTENE (PROVITAMIN A)	2500 UNIT / TAB
BIOTIN	45 MCG / TAB
CALCIUM (CALCIUM PHOSPHATE)	175 MG / TAB
CHLORIDE (POTASSIUM CHLORIDE)	50 MG / TAB
CHROMIUM (CHROMIC CHLORIDE)	50 MCG / TAB
COPPER (CUPRIC OXIDE)	2 MG / TAB
D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)	10 MG / TAB
FOLIC ACID	0.6 MG / TAB
IODINE (POTASSIUM IODIDE)	0.15 MG / TAB
IRON (FERROUS FUMARATE)	10 MG / TAB
MAGNESIUM (MAGNESIUM OXIDE)	100 MG / TAB
MANGANESE (MANGANESE SULFATE)	5 MG / TAB
MOLYBDENUM (SODIUM MOLYBDATE)	50 MCG / TAB
NICKEL (NICKEL SULFATE)	5 MCG / TAB
NICOTINAMIDE	40 MG / TAB
PHOSPHORUS (CALCIUM PHOSPHATE)	125 MG / TAB
POTASSIUM (POTASSIUM CHLORIDE)	55 MG / TAB
SELENIUM (SODIUM SELENITE)	50 MCG / TAB
SILICON (SODIUM METASILICATE)	0.01 MG / TAB
TIN (STANNOUS CHLORIDE)	0.01 MG / TAB
VANADIUM (SODIUM METAVANADATE)	10 MCG / TAB
VITAMIN A (VITAMIN A ACETATE)	3500 UNIT / TAB
VITAMIN B12 (VITAMIN B12)	20 MCG / TAB
VITAMIN B1 (THIAMINE MONONITRATE)	3 MG / TAB
VITAMIN B2	3.4 MG / TAB
VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)	5 MG / TAB
VITAMIN D (VITAMIN D3)	400 UNIT / TAB
VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)	50 UNIT / TAB
ZINC (ZINC OXIDE)	20 MG / TAB

Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.

For consumers

Resource	Description
Report a side effect	Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are: Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death; Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.

For health care professionals

Resource	Description
Report a serious adverse drug reaction (for hospitals)	Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals.

For researchers

Resource	Description
Search Clinical Information	After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.

All resources

Resource	Description
Search Clinical Information	After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.
Report a side effect	Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are: Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death; Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.
Report a serious adverse drug reaction (for hospitals)	Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals.

Resource	Description
Report a side effect	Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are: Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death; Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.

Resource	Description
Search Clinical Information	After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.

Resource	Description
Search Clinical Information	After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.

Resource	Description
Search Clinical Information	After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.
Report a side effect	Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are: Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death; Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.
Report a serious adverse drug reaction (for hospitals)	Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals.